Looking forward to SPECTRUM 2024!

“CMS’s reassignment of the histotripsy liver procedure payment rate enables Medicare patients much needed access to histotripsy and its potential benefits, to which we commend CMS,” commented HistoSonics President and CEO Mike Blue. businesswire.com/news/home/2023…

Histosonics Inc. Edison System recognized as “MedTech Innovation Of The Year”. “Histotripsy has been identified as the most meaningful transformation in tumor directed therapy in decades. said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. globenewswire.com/news-release/2…

HistoSonics, Inc. thoroughly enjoyed the visit by the St. Odilia School School's 8th Grade class last week. We are thankful to have such engaged, bright young minds join us for the day and we hope we helped in inspiring the next great innovator.

Histosonics Inc. is really looking forward to SpectrumMiami next week with our FDA cleared Edison Histotripsy System available for hands-on demonstrations and world leaders presenting on histotripsy of liver and kidney trials. #Histosonics #MiamiSpectrum #PatientsFirst

Histosonics Inc. is excited to announce the WORLD's FIRST targeted liver tumor treatments utilizing the Edison Histotripsy System following its recent FDA De Novo clearance performed at the URMC and Cleveland Clinic. #PartnershipInInnovation #Histotripsy businesswire.com/news/home/2024…

Histosonics Inc. is proud to announce the first patient with kidney tumors was treated as part of the #HOPE4KIDNEY Trial at AdventHealth Celebration using the Edison Histotripsy System. #HistoSonics #Histotripsy #PartnershipInInnovation businesswire.com/news/home/2024…

@HistoSonics is honored to have been selected to the inaugural Innovative Device Access Pathway (IDAP) pilot program in the UK to accelerate development and market access of innovative medical technology platforms across the UK health system. businesswire.com/news/home/2024…

From minimally invasive to noninvasive!! Histosonics Inc. is here Baptist Health & Miami Vascular ready to serve our patients. #cuttingedge Miami Cancer Institute Research Society of Interventional Radiology SIR RFS SIR ECS The British Society of Interventional Radiology JVIR IR Juniors ISVIR India SpectrumMiami #cancer

Histotripsy added by UNOS as a therapy option for liver transplant patients. #histosonics #noninvasive #histotripsy linkedin.com/posts/lisa-lap…

HistoSonics, Inc. is honored to be nominated for a 2024 Prix Galien Award, the United States’ preeminent prize acknowledging the leading-edge of scientific advances in life sciences. Our team shares pride in being nominated for this prestigious award! prnewswire.com/news-releases/…

@HistoSonics is honored to announce the completion of an oversubscribed $102 million Series D financing which will be used to accelerate category defining advancements to our non-invasive histotripsy platforms, commercial and clinical study expansion. businesswire.com/news/home/2024…

Histosonics Inc. is extremely proud to partner with the Li Ka Shing Foundation LiKaShing Foundation the The University of Hong Kong and The Chinese University of Hong Kong - CUHK to launch our first histotripsy program in Hong Kong. We share the excitement in making a meaningful change for the people of Hong Kong. tinyurl.com/48brujp7

Histosonics Inc. is extremely proud to have the results of our pivotal #HOPE4LIVER Trials data published today in Radiology. The trials met co-primary endpoints for technical success and safety, enabling histotripsy's quick adoption into clinical practice. businesswire.com/news/home/2024…

Congratulations to UCLA Radiology UCLA Urology UCLA Health teams for the first #RenalTumor Histosonics Inc. treatment Society of Interventional Radiology SIO KidneyCAN #HOPE4KIDNEY US

HistoSonics is excited to announced that we have been awarded an exclusive ongoing contract with the Dept. of Veterans Affairs for up to $90 million for VA hospitals to acquire novel, non-invasive Edison Histotripsy Systems for US Veterans. #Veterans businesswire.com/news/home/2024…

Histosonics Inc. is proud to announce the first patients were enrolled in our novel prospective master protocol study, called BOOMBOX, designed to evaluate the real-world use of histotripsy for treatment of liver tumors. businesswire.com/news/home/2024…

Interventional Radiology and Ohio State Wexner Medical Center Urology Dept. teams, led by Mina S. Makary, MD and Eric A. Singer, MD, MA, MS, FACS, FASCO, recently became the first in Ohio to perform histotripsy. The non-invasive procedure could significantly improve outcomes, providing world-class care while improving quality of life.

Histosonics Inc. , Inc. is honored to attend #siovegas this week in Las Vegas and to have Christos Georgiades MD, PhD. and Bruno Odisio MD, PhD. lead an interactive "Histotripsy Year In Review" panel Saturday, February 1st in the Bronze Room from 7:15 am - 8:45 am. #Histotripsy

Histosonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials. Durable local control and favorable safety profile position histotripsy as a non-invasive alternative to standard of care locoregional therapy. tinyurl.com/ytv739am